Related Experiment Videos
Platelet glycoprotein IIb/IIIa integrin blockade: recent clinical trials in interventional cardiology
1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. tchen001@mc.duke.edu
Thrombosis and Haemostasis
|July 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
GP IIb/IIIa blockade in elective percutaneous coronary intervention.
Current pharmaceutical design·2004
Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade.
Developments in biologicals·2003
Eptifibatide in percutaneous coronary intervention. A review.
Minerva cardioangiologica·2002
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).
The American journal of cardiology·2001
Immature Platelet Fraction as an Independent Marker of Adverse Outcomes in an Intensive Cardiovascular Care Unit.
Thrombosis and haemostasis·2026
Clinical Characteristics and Early Outcomes of Acute Pulmonary Embolism Presenting with Syncope.
Thrombosis and haemostasis·2026
Recent Trials of Left Atrial Appendage Closure versus Oral Anticoagulants: An Optimistic View.
Thrombosis and haemostasis·2026
Novel Levoglucosenone Derivatives: Preclinical Evaluation in Breast Cancer Models.
European journal of pharmacology·2026
Galectin-3 and its inhibitors: Overview and perspectives.
Pharmacology & therapeutics·2026
Synthetically accessible naphthalene-based rigid-core electrolytes as membrane-active antibacterial agents against drug-resistant pathogens.
European journal of medicinal chemistry·2026